News for 'All India Manufacturers Organisation'

3 cough syrups have been recalled: India replies to WHO

3 cough syrups have been recalled: India replies to WHO

Rediff.com9 Oct 2025

India's drug regulator CDSCO has recalled three cough syrups and halted their production after the WHO raised concerns about potential contamination and links to child deaths. The WHO is investigating reports of pediatric illnesses and deaths in India potentially linked to contaminated syrups.

Realty moves to the core of conglomerates' biz strategy

Realty moves to the core of conglomerates' biz strategy

Rediff.com21 Jan 2026

India's leading conglomerates are stepping up investments in real estate, recasting what was once a peripheral activity into a core growth driver. Supported by strong balance sheets, established brands and access to long-term capital, major business houses including Aditya Birla, Tata, Godrej, L&T, Raymond, Wadia, Shapoorji Pallonji, Mahindra and Adani are positioning realty as a strategic pillar within their diversified portfolios.

Was killer cough syrup exported, asks WHO to India

Was killer cough syrup exported, asks WHO to India

Rediff.com9 Oct 2025

The WHO will take a call on issuing a 'Global Medical Products Alert' on the cough syrup, Coldrif, after receiving an official confirmation from authorities here. The agency issues such alerts for substandard and contaminated medicines.

Is India Standing Alone in 2025?

Is India Standing Alone in 2025?

Rediff.com22 Dec 2025

The 2025 US National Security Strategy marks a major pullback, with America turning backward and effectively allowing China greater dominance in Asia. while long-time partners like India are left to face an increasingly unstable global order largely on their own, observes Rajeev Srinivasan.

'Will take care of it': Trump targets India over 'rice dumping'

'Will take care of it': Trump targets India over 'rice dumping'

Rediff.com9 Dec 2025

US President Donald Trump has said that India should not be "dumping" rice into the United States market and he will "take care" of it, while stressing that tariffs will solve the "problem" easily.

Listed companies' rent, lease expenses down since pandemic

Listed companies' rent, lease expenses down since pandemic

Rediff.com3 Jan 2026

Companies' rent and lease expenses have seen a significant decline relative to the money they make since the pandemic.

Govt launches all India drive to test cough syrups

Govt launches all India drive to test cough syrups

Rediff.com9 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) has initiated a nationwide campaign to test, inspect, and audit cough syrup manufacturers following concerns about contaminated products and child deaths. The initiative aims to ensure adherence to safety standards and regulatory compliance.

Govt plans SPV for aircraft manufacturing in India

Govt plans SPV for aircraft manufacturing in India

Rediff.com4 Sep 2024

The government will set up a special purpose vehicle to push ahead with plans to start manufacturing commercial aircraft in India, Civil Aviation Minister K Rammohan Naidu said on Wednesday as he highlighted the potential of the country's fast-growing aviation sector. The Bhartiya Vayuyan Vidheyak Bill 2024, which was passed by the Lok Sabha in August, includes provisions to regulate the design and manufacturing of aircraft, supporting the Aatmanirbhar Bharat initiative for self-reliance.

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

Vietnam Emerges As India's Key Defence Partner

Vietnam Emerges As India's Key Defence Partner

Rediff.com17 Nov 2025

The 15th India-Vietnam Defence Dialogue signalled a move from routine talks to deeper cooperation, with new deals on submarine rescue and defence industry to support stability in the Indo-Pacific, notes Dr Rajaram Panda.

Su-57 stealth jet, S-400 in focus during Putin's visit

Su-57 stealth jet, S-400 in focus during Putin's visit

Rediff.com3 Dec 2025

However, these are understood to be exploratory talks, with an agreement unlikely to be formalised during the current visit.

'GCCs Have Evolved To Strategic Innovation Hubs'

'GCCs Have Evolved To Strategic Innovation Hubs'

Rediff.com6 Jan 2026

'Solutions developed in India are being commercialised and offered globally because we're executing at scale, creating new markets and revenue streams.'

'India's manufacturing sector behind China'

'India's manufacturing sector behind China'

Rediff.com18 Feb 2003

India's manufacturing sector was lagging behind China and should be strengthened to increase competitiveness with that country, a study conducted by Confederation of Indian Industry and McKinsey said.

ISRO lines up 7 launches by Mar, including Gaganyaan uncrewed mission

ISRO lines up 7 launches by Mar, including Gaganyaan uncrewed mission

Rediff.com14 Dec 2025

ISRO has announced plans for seven launch missions by March, including the first uncrewed mission for the Gaganyaan project and demonstrations of new satellite technologies.

ISRO planning 7 more launches this financial year

ISRO planning 7 more launches this financial year

Rediff.com16 Nov 2025

Indian Space Research Organisation is gearing up for one of its busiest times with seven more launches planned this financial year, even as India's first human spaceflight remains scheduled for 2027, its chairman V Narayanan said.

Actor-director Siddhanth Kapoor quizzed in drug seizure case

Actor-director Siddhanth Kapoor quizzed in drug seizure case

Rediff.com26 Nov 2025

Bollywood actor-director Siddhanth Kapoor was questioned by Mumbai police in connection with a drug seizure case. The Anti-Narcotics Cell (ANC) also summoned influencer Orhan Awatramani. The investigation is linked to a Rs 252 crore mephedrone seizure case.

'Indian Youth Can Expect Career Growth In Russia'

'Indian Youth Can Expect Career Growth In Russia'

Rediff.com4 Dec 2025

'Don't look at Russia only as a place to earn quickly and then leave.' 'Try to build experience in serious companies, skills and certifications that will serve you anywhere in the world.'

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

Automation Takes the Lead, Hiring Trails

Automation Takes the Lead, Hiring Trails

Rediff.com29 Oct 2025

Eight of the top 10 employers showed a double-digit growth in fixed capital. Only one out of 10 showed a double-digit addition in employment.

Govt in talks to streamline FDI, FII processes: Goyal

Govt in talks to streamline FDI, FII processes: Goyal

Rediff.com19 Nov 2025

The Centre is regularly holding consultations with stakeholders to streamline foreign direct investments (FDIs) and foreign institutional investments (FIIs) related processes to enable faster and more efficient investment flows into the country, said Commerce and Industry Minister Piyush Goyal, adding one such meeting with stakeholders was held on Tuesday.

Tariffs: India Inc Cautions Against Knee-jerk Reaction

Tariffs: India Inc Cautions Against Knee-jerk Reaction

Rediff.com19 Aug 2025

Industry leaders urge India to pursue diplomatic talks with the US, strengthen manufacturing, and consider China ties to gain leverage against tariff pressures.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

China opposes US tariffs on India amid thaw in Sino-India ties

China opposes US tariffs on India amid thaw in Sino-India ties

Rediff.com22 Aug 2025

Chinese envoy Xu Feihong stated that China opposes the US imposing tariffs on India, amidst a thaw in Sino-India relations and concerns over global trade disruptions.

India to send man into space by 2027, land on Moon by 2040

India to send man into space by 2027, land on Moon by 2040

Rediff.com15 Oct 2025

ISRO Chairman V Narayanan announces ambitious space program goals, including landing Indians on the Moon by 2040 and launching the 'Gaganyaan' mission in 2027. The agency is also working on a national space station and uncrewed missions.

TN special teams to monitor drug firms after cough syrup deaths

TN special teams to monitor drug firms after cough syrup deaths

Rediff.com17 Oct 2025

Tamil Nadu has formed special teams to monitor drug manufacturers after deaths of infants in Madhya Pradesh were linked to a cough syrup made by a Tamil Nadu-based company. Inspections are being conducted at pharmaceutical firms across the state.

Kingpin in Rs 252-cr meow-meow haul nabbed after Dubai deportation

Kingpin in Rs 252-cr meow-meow haul nabbed after Dubai deportation

Rediff.com23 Oct 2025

Mumbai police have arrested Mohammed Salim Mohammed Suhail Shaikh, a key accused in a Rs 252-crore mephedrone seizure case, after his deportation from Dubai. Shaikh, known as 'Lavish,' is a member of an international drug syndicate and managed the supply and distribution chain from Dubai.

Andhra all set for huge investments from Adani Group, Reliance

Andhra all set for huge investments from Adani Group, Reliance

Rediff.com15 Nov 2025

Adani Group said on Friday it will invest around Rs 1 trillion in various sectors of Andhra Pradesh over the next ten years, deepening its commitment in the state where it will partner with Google for an artificial intelligence (AI) hub in Visakhapatnam.

'After GST cut, innovation will boost life insurance'

'After GST cut, innovation will boost life insurance'

Rediff.com5 Dec 2025

The reduction in goods & services tax (GST) on individual life and health insurance premiums has been called a "landmark step" for making insurance affordable and inclusive. In a panel discussion at the Business Standard BFSI Insight Summit 2025, Anup Bagchi, managing director (MD) & chief executive officer (CEO) of ICICI Prudential Life Insurance; Mahesh Balasubramanian, MD & CEO of Kotak Life Insurance; Tarun Chugh, MD & CEO of Bajaj Life Insurance; and Ratnakar Patnaik, MD of Life Insurance Corporation of India (LIC), listed what else the industry needs to reach more people.

'We Have Become The Largest Eyewear Brand In Asia'

'We Have Become The Largest Eyewear Brand In Asia'

Rediff.com5 Nov 2025

'India needs at least 70,000 to 80,000 eyewear stores; our 2,000 stores are just a drop in the ocean.'

Stocks for Diwali 2025: Shares That Historically Outperform in Oct-Nov

Stocks for Diwali 2025: Shares That Historically Outperform in Oct-Nov

Rediff.com14 Oct 2025

The Indian stock market in the October-November period sees high trading activity due to increased consumer spending, festive demand, upbeat sentiment, renewed investor confidence, and the auspicious Muhurat trading session. This impacts many stocks and sectors in the festive season.

Trump's tariffs hurting India, causing job loss: Tharoor

Trump's tariffs hurting India, causing job loss: Tharoor

Rediff.com12 Sep 2025

Senior Congress leader Shashi Tharoor says US tariffs are negatively impacting India, leading to job losses, and criticizes President Trump's diplomatic behavior.

112,000 Tech Jobs Have Vanished In 2025 So Far

112,000 Tech Jobs Have Vanished In 2025 So Far

Rediff.com24 Nov 2025

...compared with 153,000 in all of 2024.

US Needs India As Much As India Needs The US

US Needs India As Much As India Needs The US

Rediff.com6 Sep 2025

India-US relations, like Rome, were not built in a day, nor can they be demolished in a day.
All said and done, when the new global order emerges, India can only remain with the democracies, asserts Ambassador T P Sreenivasan.

Running for top spot, Asics eyes Nike and Adidas turf in India

Running for top spot, Asics eyes Nike and Adidas turf in India

Rediff.com14 Aug 2025

It has charted an ambitious target. Japanese premium sports goods giant Asics - which sells 75 per cent of its shoes in the country at over ~12,000 a pair - wants to be the No. 1 running shoe player in the $90-a-pair organised market in India, currently dominated by Nike, Adidas and Puma. To do so, it is making an aggressive push into Tier-II and Tier-III cities, where customers are ready to lap them up - as well as setting up company-owned stores in four to five locations across key metros.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

SC Nod For Green Crackers; Sale Restricted In Delhi-NCR

SC Nod For Green Crackers; Sale Restricted In Delhi-NCR

Rediff.com26 Sep 2025

The Supreme Court has allowed certified manufacturers to produce green crackers, but restricted their sale in Delhi-NCR without approval. The court has asked the Centre to review the ban on firecracker manufacturing in the region.

'Can't be blaming weather, you continue to execute'

'Can't be blaming weather, you continue to execute'

Rediff.com13 Nov 2025

'The DNA of Tata Consumer Products is all food and beverage.'

How A Silk Sari Started A Fashion Revolution

How A Silk Sari Started A Fashion Revolution

Rediff.com5 Dec 2025

'Women weavers are hardworking, open to learning, resilient.' 'They finish their cooking, housework, puja, then they come to weave.' 'They care about design. They care about beauty.'

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.